NEW YORK—Non-AIDS defining cancers are increasingly important contributors to health outcomes for aging persons with HIV (PWH), according to a recent conference presentation which also pointed out that, although prostate cancer is prevalent in aging... View Article
LA JOLLA, CA—Research has been conflicting on whether androgen deprivation therapy is related to dementia. A research letter in JAMA Oncology pointed out that two studies reported a strong statistically significant association between ADT and... View Article
MADISON, WI—How does a history of Agent Orange exposure affect prostate cancer survival in VA patients receiving androgen deprivation therapy for advanced prostate cancer? That was the question addressed in a Journal of Urology study.1... View Article
CHICAGO—The pace of U.S. Food and Drug Administration approval of oral anticancer medications has rapidly increased, from less than one a year at the turn of the century to 10 in 2018. While patients generally... View Article
FORT BRAGG, NC—Immunization rates of human papilloma virus (HPV) have risen among active duty forces, but many fail to complete the full vaccine series, despite recommendations from the Defense Health Agency. “DHA fully endorses... View Article
BOSTON — With an aging population, cognitive impairment is increasingly common. The question raised by a new study was what effect that has on survival for older patients with hematologic cancers.
The number of clinical trials open to veterans with cancer in the New England region (VISN 1) grows every week, leading a return to the prominence the VA had in trial programs in decades past and offering veterans access to the “gold standard” of treatment in oncology.
After decades on the sidelines, research in cutaneous T-cell lymphoma (CTCL) has exploded in recent years, bringing patients with this rare disease new opportunities for treatment.
The U.S. Food and Drug Administration approval of several tyrosine kinase inhibitors (TKIs) over the last decade has substantially improved outcomes for patients with metastatic renal cell carcinoma.
After years of apparently rising rates of kidney cancer, the incidence of early-stage disease seems to be declining, at least in California.
DURHAM, NC—What is the association between lowest prostate-specific antigen (PSA) and time to nadir with biochemical recurrence (BCR) risk after radical prostatectomy (RP)? A study published recently in the journal Urology used the SEARCH database... View Article
DURHAM, NC—Visceral metastases (VMs) are generally believed to predict worse prognoses compared with bone and lymph metastases in men with metastatic castration-resistant prostate cancer (mCRPC). Still, a new study published in the journal European Urology... View Article
EAST NORTHPORT, NY—Being diagnosed with prostate cancer can be difficult enough. But what happens when the patient also is a veteran with post-traumatic stress disorder (PTSD)? A presentation at the 2017 American Society of Clinical... View Article
Colorectal cancer data from the VA often is underrepresented in U.S. cancer reporting, according to a new study seeking to remedy that.
While young and middle-aged patients are much more likely to receive postoperative chemotherapy than older patients, they don't appear to survive any longer from colon cancer, a new study reported.
How is chronic myeloid leukemia (CML) treated over an extended period at the VHA, including the use of tyrosine kinase inhibitor (TKI) therapy with imatinib, dasatinib and nilotinib?
Hepatitis C virus (HCV) infection is known to cause hepatocellular carcinoma (HCC) and subtypes of non-Hodgkin lymphoma (NHL).
© 2000-2017. All Materials Copyright Marathon Medical Communications, Inc.